Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Lenvatinib With or Without Everolimus in Patients With Metastatic Renal Cell Carcinoma After Immune Checkpoint Inhibitors and VEGFR-TKI TherapiesOncologist 2021 Mar 31;[EPub Ahead of Print], AJ Wiele, TK Bathala, AW Hahn, L Xiao, M Duran, JA Ross, E Jonasch, AY Shah, MT Campbell, P Msaouel, NM Tannir
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.